COVID-19 antiviral drugs

Simple item page
dc.contributor.authorFrick, David N.
dc.contributor.authorLee, Benhur
dc.contributor.authorSeley-Radtke, Katherine
dc.contributor.authorWang, Jun
dc.date.accessioned2024-03-06T18:52:14Z
dc.date.available2024-03-06T18:52:14Z
dc.date.issued2021-12-01
dc.description.urihttps://www.sciline.org/covid-19/quotes-antiviral-molnupiravir-paxlovid/
dc.format.extent12 pages
dc.genrearticles
dc.genreinterviews
dc.identifierdoi:10.13016/m2qekh-4ovf
dc.identifier.citationFrick, David N., Benhur Lee, Katherine Seley-Radtke, and Jun Wang. “COVID-19 Antiviral Drugs.” SciLine (blog), December 1, 2021. https://www.sciline.org/covid-19/quotes-antiviral-molnupiravir-paxlovid/.The following values have no corresponding Zotero field:periodical: SciLine
dc.identifier.urihttp://hdl.handle.net/11603/31833
dc.language.isoen_US
dc.publisherAAAS
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Faculty Collection
dc.relation.ispartofUMBC Chemistry & Biochemistry Department
dc.rightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
dc.subjectCOVID-19 antiviral drugs
dc.subjectMerck’s molnupiravir
dc.subjectPfizer’s Paxlovid
dc.titleCOVID-19 antiviral drugs
dc.typeText
dcterms.creatorhttps://orcid.org/0000-0002-0154-3459

Files

Collections

UMBC Faculty Collection
UMBC Chemistry & Biochemistry Department